Study: MBI effective, less costly for diagnosing breast cancer

05/2/2013 | AuntMinnie.com (free registration)

Molecular breast imaging can identify 95% of cancers and locate ductal carcinoma and lobular carcinoma as well as lesions smaller than 1 centimeter, according to a study published in the European Journal of Nuclear Medicine and Molecular Imaging. The review also found that MBI's sensitivity for breast cancer was similar to that of MRI, but MBI has higher specificity and costs less. "Current evidence suggests that BSGI is an extremely useful adjunct to mammography for its ability to identify breast cancer with a high diagnostic performance," researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN